| Market Cap | ₹26,884Cr |
| ROE | 1.12% |
| P/E Ratio(TTM) | 273.31 |
| EPS(TTM) | 0.74 |
| P/B Ratio | 3.31 |
| Dividend Yield | 0.07% |
| Industry P/E | 35.13 |
| Book Value | 61.17 |
| Debt to Equity | 0.60 |
| Face Value | 10 |
| Parent Organisation | Piramal Pharma |
| NSE Symbol | PPLPHARMA |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | NA (0.00%) | 39.22 | ||
| Cipla | NA (0.00%) | 23.76 | ||
| Dr Reddy's Laboratories | NA (0.00%) | 18.66 | ||
| Zydus Lifesciences | NA (0.00%) | 21.48 |